The bill increases transparency and gives businesses and policymakers clearer information to counter foreign economic coercion, but it also raises compliance and administrative costs and risks diplomatic friction from publicly naming boycott actors.
U.S. businesses, including small exporters, receive clearer, up-to-date information about foreign boycott risks through a mandated public inventory, helping them avoid legal exposure under the Anti-Boycott Act.
Federal policymakers and oversight bodies gain a regular, public inventory of foreign governments and organizations that foster or impose covered boycotts, improving transparency and enabling congressional and executive oversight.
U.S. diplomatic and national-security actors benefit from annual public reporting that documents hostile economic coercion, strengthening the factual basis for diplomatic, sanctions, or policy responses.
Small businesses and individuals could face expanded compliance burdens and greater enforcement risk if the amended policy broadens the statute's coverage.
Countries or organizations publicly named as fostering boycotts may be subject to diplomatic strain or reciprocal actions, which could complicate U.S. foreign relations and trade ties.
Annual reporting by the President creates recurring administrative costs and could generate political friction between the executive branch and other stakeholders over the contents and handling of the list.
Based on analysis of 2 sections of legislative text.
Amends the Anti‑Boycott Act with new statutory insertions and requires the President to publish an annual report naming countries and international organizations that foster covered boycotts.
Introduced January 31, 2025 by Michael Lawler · Last progress January 31, 2025
Amends the existing Anti-Boycott Act to add new policy language and targeted changes to the statute’s text and to require the President to produce and publish an annual report identifying foreign countries and international organizations that foster or impose boycotts covered by the law. The measure does not specify new funding and mainly changes statutory wording and reporting responsibilities, which may alter compliance obligations for U.S. entities involved in covered transactions.